Royalty Pharma plc Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 2.70 B

Royalty Pharma plc Operating Cash Flow is USD 2.70 B for the Trailing 12 Months (TTM) ending March 31, 2025, a 3.12% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Royalty Pharma plc Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 2.62 B, a -3.64% change year over year.
  • Royalty Pharma plc Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 2.72 B, a 39.24% change year over year.
  • Royalty Pharma plc Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 1.95 B.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities